|
1
|
Polkinghorn WR and Tarbell NJ:
Medulloblastoma: tumorigenesis, current clinical paradigm, and
efforts to improve risk stratification. Nat Clin Pract Oncol.
4:295–304. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rossi A, Caracciolo V, Russo G, Reiss K
and Giordano A: Medulloblastoma: From molecular pathology to
therapy. Clin Cancer Res. 14:971–976. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gilbertson RJ: Medulloblastoma: signalling
a change in treatment. Lancet Oncol. 5:209–218. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cho YJ, Tsherniak A, Tamayo P, et al:
Integrative genomic analysis of medulloblastoma identifies a
molecular subgroup that drives poor clinical outcome. J Clin Oncol.
29:1424–1430. 2011. View Article : Google Scholar :
|
|
5
|
Kool M, Koster J, Bunt J, et al:
Integrated genomics identifies five medulloblastoma subtypes with
distinct genetic profiles, pathway signatures and
clinicopathological features. PLoS One. 3:e30882008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Thompson MC, Fuller C, Hogg TL, et al:
Genomics identifies medulloblastoma subgroups that are enriched for
specific genetic alterations. J Clin Oncol. 24:1924–1931. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zollo M: Genetics of recurrent
medulloblastoma. Lancet Oncol. 14:1147–1148. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gilbertson RJ and Ellison DW: The origins
of medulloblastoma subtypes. Annu Rev Pathol. 3:341–365. 2008.
View Article : Google Scholar
|
|
9
|
Eberhart CG: Molecular diagnostics in
embryonal brain tumors. Brain Pathol. 21:96–104. 2011. View Article : Google Scholar
|
|
10
|
Reed ML and Leff SE: Maternal imprinting
of human SNRPN, a gene deleted in Prader-Willi syndrome. Nat Genet.
6:163–167. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bussey KJ, Lawce HJ, Himoe E, et al: SNRPN
methylation patterns in germ cell tumors as a reflection of
primordial germ cell development. Genes Chromosomes Cancer.
32:342–352. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Benetatos L, Hatzimichael E, Dasoula A, et
al: CpG methylation analysis of the MEG3 and SNRPN imprinted genes
in acute myeloid leukemia and myelodysplastic syndromes. Leuk Res.
34:148–153. 2010. View Article : Google Scholar
|
|
13
|
Hashimoto K, Azuma C, Kamiura S, et al:
Maintenance of imprinting of the insulin-like growth factor II gene
(IGF2) and the small nuclear ribonucleoprotein polypeptide N gene
(SNRPN) in the human uterus and leiomyoma. Gynecol Obstet Invest.
41:50–54. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee SH, Appleby V, Jeyapalan JN, et al:
Variable methylation of the imprinted gene, SNRPN, supports a
relationship between intracranial germ cell tumours and neural stem
cells. J Neurooncol. 101:419–428. 2011. View Article : Google Scholar
|
|
15
|
Finn S, Smyth P, O’Regan E, et al:
Low-level genomic instability is a feature of papillary thyroid
carcinoma: an array comparative genomic hybridization study of
laser capture microdissected papillary thyroid carcinoma tumors and
clonal cell lines. Arch Pathol Lab Med. 131:65–73. 2007.PubMed/NCBI
|
|
16
|
Sakoda T, Kasahara N, Hamamori Y and Kedes
L: A high-titer lentiviral production system mediates efficient
transduction of differentiated cells including beating cardiac
myocytes. J Mol Cell Cardiol. 31:2037–2047. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Soneoka Y, Cannon PM, Ramsdale EE, et al:
A transient three-plasmid expression system for the production of
high titer retroviral vectors. Nucleic Acids Res. 23:628–633. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tiscornia G, Singer O and Verma IM:
Production and purification of lentiviral vectors. Nat Protoc.
1:241–245. 2006. View Article : Google Scholar
|
|
19
|
Rubin JB and Rowitch DH: Medulloblastoma:
A problem of developmental biology. Cancer Cell. 2:7–8. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wechsler-Reya R and Scott MP: The
developmental biology of brain tumors. Annu Rev Neurosci.
24:385–428. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mabbott DJ, Spiegler BJ, Greenberg ML,
Rutka JT, Hyder DJ and Bouffet E: Serial evaluation of academic and
behavioral outcome after treatment with cranial radiation in
childhood. J Clin Oncol. 23:2256–2263. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ellison DW, Dalton J, Kocak M, et al:
Medulloblastoma: clinicopathological correlates of SHH, WNT, and
non-SHH/WNT molecular subgroups. Acta Neuropathol. 121:381–396.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Northcott PA, Hielscher T, Dubuc A, et al:
Pediatric and adult sonic hedgehog medulloblastomas are clinically
and molecularly distinct. Acta Neuropathol. 122:231–240. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang LH: Molecular signaling regulating
anchorage-independent growth of cancer cells. Mt Sinai J Med.
71:361–367. 2004.PubMed/NCBI
|
|
25
|
Ohosone Y, Mimori T, Griffith A, et al:
Molecular cloning of cDNA encoding Sm autoantigen: derivation of a
cDNA for a B polypeptide of the U series of small nuclear
ribonucleoprotein particles. Proc Natl Acad Sci USA. 86:4249–4253.
1989. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Agarwal ML, Agarwal A, Taylor WR and Stark
GR: p53 controls both the G2/M and the G1 cell cycle checkpoints
and mediates reversible growth arrest in human fibroblasts. Proc
Natl Acad Sci USA. 92:8493–8497. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Niculescu AB III, Chen X, Smeets M, Hengst
L, Prives C and Reed SI: Effects of p21(Cip1/Waf1) at both the G1/S
and the G2/M cell cycle transitions: pRb is a critical determinant
in blocking DNA replication and in preventing endoreduplication.
Mol Cell Biol. 18:629–643. 1998.PubMed/NCBI
|
